| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.31 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |